Fig. 7From: Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaModel calibration and ROC evaluation. A KM survival curve of patients in the high-risk and low-risk groups. B Nomogram for predicting 1-, 3-, 5-, and 10-year OS for ccRCC patients. ROC curves of clinicopathological characters (green, integrated with tumor stage diagnoses, age and neoplasm histologic grade), RiskScore (red) and NomoScore (black), at 1 (C), 3 (D), 5 (E), and 10Â years (F)Back to article page